SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-22-010418
Filing Date
2022-03-15
Accepted
2022-03-15 16:32:13
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 ubx-s3.htm S-3 707988
2 EX-1.2 ubx-ex12_9.htm EX-1.2 275209
3 EX-5.1 ubx-ex51_8.htm EX-5.1 45008
4 EX-23.1 ubx-ex231_7.htm EX-23.1 4517
5 EX-FILING FEES ubx-exfilingfees_6.htm EX-FILING FEES 41737
6 GRAPHIC g2jfyx2tmzxs000002.jpg GRAPHIC 58309
7 GRAPHIC g2jfyx2tmzxs000001.jpg GRAPHIC 58591
8 GRAPHIC go3rnykxjj3e000001.jpg GRAPHIC 437001
9 GRAPHIC go3rnykxjj3e000002.jpg GRAPHIC 437001
10 GRAPHIC go3rnykxjj3e000003.jpg GRAPHIC 437001
  Complete submission text file 0001564590-22-010418.txt   3042526
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-263574 | Film No.: 22741587
SIC: 2834 Pharmaceutical Preparations